oseltamivir has been researched along with Weight Loss in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Hu, Y; Liu, H; Tang, CC; Xiang, TN; Ye, XL; Zheng, YJ | 1 |
Hensen, L; Hurt, AC; Kedzierska, K; Kedzierski, L; Koutsakos, M; Mercuri, F; Mifsud, E; NĂ¼ssing, S; Rossignol, JF; Wang, Z | 1 |
Boonnak, K; Orandle, M; Subbarao, K; Talor, E; Vogel, L; Zimmerman, D | 1 |
Chen, J; Chen, X; Deng, L; Nie, J; Pang, P; Wu, S; Xu, H; Zheng, K | 1 |
Leyva-Grado, VH; Palese, P | 1 |
Hino, A; Kurokawa, M; Park, YK; Shimizu, T; Tsutsumi, A; Watanabe, W | 1 |
Macintire, DK; Savigny, MR | 1 |
Choi, HJ; Kwon, DH; Song, JH | 1 |
Hurst, BL; Smee, DF; Wong, MH | 1 |
Carroll, MW; Cheung, L; Dimmock, NJ; Dove, BK; Easton, AJ; Hallis, B; Marriott, AC; Meng, B; Scott, PD; Taylor, I | 1 |
1 trial(s) available for oseltamivir and Weight Loss
Article | Year |
---|---|
Use of oseltamivir in the treatment of canine parvoviral enteritis.
Topics: Animals; Antiviral Agents; Dog Diseases; Dogs; Enteritis; Female; Leukocyte Count; Male; Oseltamivir; Parvoviridae Infections; Parvovirus, Canine; Prospective Studies; Treatment Outcome; Weight Loss | 2010 |
9 other study(ies) available for oseltamivir and Weight Loss
Article | Year |
---|---|
[Reduning Injection protects flu-infected mice by inhibiting infiltration of inflammatory cells in lung and down-regulating cytokine storm].
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Chemokine CCL5; Chemokine CXCL10; Cytokine Release Syndrome; Cytokines; Drugs, Chinese Herbal; Female; Imiquimod; Interleukin-10; Interleukin-6; Lung; Mice; Mice, Inbred C57BL; Oseltamivir; Phosphates; RNA; RNA, Messenger; Tumor Necrosis Factor-alpha; Weight Loss | 2022 |
Viral burden, inflammatory milieu and CD8
Topics: Animals; Antiviral Agents; Bronchoalveolar Lavage Fluid; CD8-Positive T-Lymphocytes; Cytokines; Inflammation; Influenza A virus; Killer Cells, Natural; Lung; Mice; Neutrophils; Orthomyxoviridae Infections; Oseltamivir; Thiazoles; Viral Load; Weight Loss | 2020 |
Antigen-activated dendritic cells ameliorate influenza A infections.
Topics: Animals; Antigens, Viral; Antiviral Agents; CD8-Positive T-Lymphocytes; Cells, Cultured; Combined Modality Therapy; Dendritic Cells; Drug Resistance, Viral; Female; Humans; Immunotherapy; Influenza A Virus, H1N1 Subtype; Lung; Male; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir; Peptide Fragments; Viral Load; Virus Replication; Weight Loss | 2013 |
Forsythoside A Controls Influenza A Virus Infection and Improves the Prognosis by Inhibiting Virus Replication in Mice.
Topics: Animals; Antiviral Agents; Gene Expression Regulation; Glycosides; Influenza A virus; Lung; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Orthomyxoviridae Infections; Oseltamivir; Prognosis; Random Allocation; Real-Time Polymerase Chain Reaction; Signal Transduction; Toll-Like Receptor 7; Virus Replication; Weight Loss | 2016 |
Aerosol administration increases the efficacy of oseltamivir for the treatment of mice infected with influenza viruses.
Topics: Administration, Oral; Aerosols; Animals; Antiviral Agents; Disease Models, Animal; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H7N9 Subtype; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir; Survival Rate; Weight Loss | 2017 |
Anti-influenza virus activity of propolis in vitro and its efficacy against influenza infection in mice.
Topics: Administration, Oral; Animals; Antiviral Agents; Brazil; Bronchoalveolar Lavage Fluid; Female; Influenza A Virus, H1N1 Subtype; Lung; Mice; Mice, Inbred DBA; Orthomyxoviridae Infections; Oseltamivir; Propolis; Viral Load; Viral Plaque Assay; Weight Loss | 2008 |
Quercetin 3-rhamnoside exerts antiinfluenza A virus activity in mice.
Topics: Animals; Antiviral Agents; Cell Line; Dogs; Influenza A virus; Lung; Male; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir; Phytotherapy; Quercetin; Viral Load; Virus Cultivation; Weight Loss | 2012 |
Effects of TheraMax on influenza virus infections in cell culture and in mice.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Camellia sinensis; Cell Line; Dogs; Drug Evaluation, Preclinical; Hemorrhage; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza B virus; Lung; Lung Diseases; Mice; Mice, Inbred BALB C; Nasal Cavity; Orthomyxoviridae Infections; Oseltamivir; Plant Extracts; Sambucus; Toxicity Tests; Weight Loss | 2011 |
Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir.
Topics: Animals; Antiviral Agents; Cell Line; Defective Viruses; Ferrets; Hemagglutination Inhibition Tests; Influenza A Virus, H1N1 Subtype; Male; Nasal Lavage Fluid; Orthomyxoviridae Infections; Oseltamivir; RNA, Viral; Transfection; Weight Loss | 2012 |